Thermo Fisher Scientific Inc (TMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 10,710,000 | 11,450,000 | 10,677,000 | 10,970,000 | 11,818,000 |
| Cost of Goods | 6,570,000 | 6,844,000 | 6,375,000 | 6,371,000 | 6,354,000 |
| Gross Profit | 4,140,000 | 4,606,000 | 4,302,000 | 4,599,000 | 5,464,000 |
| Operating Expenses | 2,577,000 | 2,745,000 | 2,592,000 | 2,598,000 | 2,643,000 |
| Operating Income | 1,563,000 | 1,861,000 | 1,710,000 | 2,001,000 | 2,821,000 |
| Interest Expense | 300,000 | 269,000 | 173,000 | 148,000 | 136,000 |
| Other Income | 75,000 | 155,000 | -8,000 | 13,000 | -164,000 |
| Pre-tax Income | 1,338,000 | 1,747,000 | 1,529,000 | 1,866,000 | 2,521,000 |
| Income Tax | 46,000 | 173,000 | 31,000 | 198,000 | 301,000 |
| Net Income Continuous | 1,292,000 | 1,574,000 | 1,498,000 | 1,668,000 | 2,220,000 |
| Minority Interests | 3,000 | -2,000 | 3,000 | 4,000 | 5,000 |
| Net Income | $1,289,000 | $1,576,000 | $1,495,000 | $1,664,000 | $2,215,000 |
| EPS Basic Total Ops | 3.34 | 4.02 | 3.82 | 4.25 | 5.66 |
| EPS Basic Continuous Ops | 3.35 | 4.02 | 3.82 | 4.26 | 5.66 |
| EPS Diluted Total Ops | 3.32 | 4.01 | 3.79 | 4.22 | 5.61 |
| EPS Diluted Continuous Ops | 3.33 | 4.02 | 3.79 | 4.23 | 5.62 |
| EBITDA(a) | $2,422,000 | $2,709,000 | $2,548,000 | $2,837,000 | $3,680,000 |